Results 301 to 310 of about 106,446 (312)

ACE inhibitors/angiotensin receptor blockers

Reactions Weekly, 2021
openaire   +1 more source

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

New England Journal of Medicine, 2001
exaly  

Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin‐converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)‐Added trial

European Journal of Heart Failure, 2008
Christopher B Granger, Salim Yusuf, Karl Swedberg   +2 more
exaly  

Angiotensin receptor blockers in essential hypertension

The Lancet, 1993
openaire   +2 more sources

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

Lancet, The, 2010
exaly  

Azilsartan Medoxomil: A New Angiotensin Receptor Blocker

Clinical Therapeutics, 2011
exaly  

Angiotensin-receptor blockers: Another victory

Current Hypertension Reports, 2002
openaire   +1 more source

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Lancet, The, 2005
exaly  

Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction

Lancet, The, 1994
exaly  

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

2006
openaire   +1 more source